Résumé
Chemoradiation therapy combined with brachytherapy changed dramatically the prognosis of advanced uterine cervical cancer. MRI is a key examination to determine treatment response evaluation. Nevertheless, interpretation may be challenging due to post-therapeutic changes and inflammatory lesions seen on MRI, which can lead to false positives and useless surgical treatment. Diffusion-weighted imaging (DWI) sequences may improve MRI specificity, and reduce the number of false positives. Follow-up MRI may also be an option in case if benign post-treatment changes are suspected. It is mandatory to detect tumor recurrences. Systematic imaging follow-up is not recommended, except when trachelectomy has been performed. MRI is required in case of clinical symptoms. PET-CT remains an accurate examination to detect and stage recurrences before pelvic exenteration.
Titre traduit de la contribution | Post-therapeutic features of uterine cervical cancer |
---|---|
langue originale | Français |
Pages (de - à) | 199-208 |
Nombre de pages | 10 |
journal | Imagerie de la Femme |
Volume | 23 |
Numéro de publication | 4 |
Les DOIs | |
état | Publié - 1 janv. 2013 |
Modification externe | Oui |
mots-clés
- Brachytherapy
- Chemoradiation therapy
- MRI
- Post-treatment changes
- Recurrence
- Uterine cervical cancer